DNA and Gene Cloning Services Market

DNA and Gene Cloning Services Market Size Overview

The global DNA and gene cloning services market, valued at USD 3.12 billion in 2025, is projected to reach USD 3.57 billion in 2026 and USD 14.55 billion by 2035, with a 16.9% CAGR during the forecast period 2026 to 2035.

To learn more about this report, request a free sample copy

DNA and gene cloning services are essential for diverse fields of research, biotechnology, and medicine applications. In 1973, a team of scientists made a groundbreaking discovery. They found that individual genes could be replicated and isolated through enzymatic cleaving of DNA into fragments. Since then, gene and DNA cloning have become indispensable tools for genetic research. Over time the continuous advancements in genetic engineering and cloning have opened up exciting possibilities for scientists. 

With respect to this, By changing the genomes of tiny organisms, substances with all sorts of uses in research and medicine can be obtained. For instance, gene cloning can help to make therapies for diseases such as cystic fibrosis, cancer, and AIDS. Moreover it is being explored as a way to address the shortage of organ donors, concerning, traditional organ transplantation faces challenges including donor shortages and compatibility issues. However, cloning provides a transformative approach such as, by cloning healthy tissues or organs from a patient's own cells, reducing the risk of rejection and expanding the potential for more accessible and personalized organ transplantation solutions. 

Additionally, gene cloning presents a fascinating solution to organ scarcity and serves as an essential tool in synthesizing antibiotics, vitamins and hormones. Given its wide range of applications, scientists are vigorously involved in creating gene libraries containing collections of cloned DNA. Despite its potential, there are some challenges such as gene toxicity, tricky DNA structures, and the requirement for specific-sized inserts. To tackle these hurdles and ensure top-notch results, various companies are turning to outsourcing for their gene cloning needs. Consequently, these challenges have generated lucrative opportunities for companies offering a diverse range of DNA and gene cloning services such as gene synthesis, expression optimization, and custom vector construction to meet specific research needs.

Furthermore, a surge in demand for gene therapies and increasing adoption of novel and advanced DNA cloning technologies are driving the potential growth of the DNA and gene cloning service market. Numerous pharmaceutical and biotechnology companies are leveraging their expertise and providing a variety of DNA and gene cloning services for different genes. The majority of the small startup companies are offering a wide range of services.

DNA and Gene Cloning Services Market Share Insights

The market research report presents an in-depth analysis of the various companies that are engaged in the global market of DNA and gene cloning service across different segments, as defined in the table below:

Global DNA and Gene Cloning Services Market: Report Attributes / Market Segmentations

One of the key objectives of this DNA and gene cloning services market report was to estimate the current market size, opportunity, and future growth potential of the DNA and gene cloning services market, over the forecast period. Based on multiple parameters, likely adoption trends, and through primary validations, we have provided an informed estimate of the market evolution during the forecast period till 2035. The market report also features the likely distribution of the current and forecasted opportunity within the DNA and gene cloning services market across various segments, such as type of service offered (gene synthesis, custom cloning, sub-cloning, and others), type of gene (standard gene, complex gene and others), company size (small, mid-sized and large), end-user industry (academic and R&D, pharmaceutical and biotechnology companies, and others) and key geographical regions (North America, Europe and Asia Pacific, Latin America, Middle East, North Africa and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

DNA and Gene Cloning Services Market Segmentation Overview

DNA and Gene Cloning Services Market Share by Type of Service Offered

The global DNA and gene cloning services market is split into several types of services, such as Gene Synthesis, Custom Cloning, Sub-cloning, and Others. Based on the types of services, custom cloning accounts for 47% of the DNA and gene cloning services market shares and is likely to uplift the market growth at a CAGR of 17.31% throughout this projection period. The advantages of custom cloning in tailored solutions, the complexity of genetic engineering projects, and flexibility in DNA construct design are some of the factors attributed to spur the DNA and gene cloning services market growth during this forecast period. 

DNA and Gene Cloning Services Market Share by Type of Gene

This segment underscores the type of gene in the DNA and gene cloning services market, Based on the type of gene, the market is bifurcated into Standard Genes, Complex Genes, and others. Complex genes acquire the highest 55% of the market share and are likely to boost the market growth at a CAGR of 16.74% during the forecast period. Complex genes require customized cloning strategies and specialized services due to their intricate structure and regulatory elements which boosts market growth with a higher demand for tailored DNA and gene cloning services.

DNA and Gene Cloning Services Market Share by Type of Company Size

Based on the type of company size, the DNA and gene cloning services market is fragmented into Small, Mid-sized, and Large. In terms of revenue, large companies acquire 60% of the total market share and are anticipated to propel the market growth at a CAGR of 19.69%. Due to the extensive resources, established reputations, economies of scale, and advanced technology in DNA and gene cloning, large companies are expected to continue to lead the market growth over this forecast period.

DNA and Gene Cloning Services Market Share by Type of End-User

The DNA and gene cloning services market serves a diverse range of end-user industries such as Academic and R&D, Pharmaceutical and Biotechnology Companies, and Others. Based on the type of end-user, pharmaceutical and biotechnology companies capture around 57% of the market share by 2035. The academic and R&D segment is projected to accelerate the market at a CAGR of 16.36% during this forecast period. This growth is attributed to the rapidly evolving biomedical field and the benefits offered by these services, such as providing accurate, quick, and desired constructs. These advantages enable end-users to streamline their research processes and focus on other critical areas of study.

DNA and Gene Cloning Services Market Share by Type of Key Geographical Regions

This segment highlights the distribution of the DNA and gene cloning services market across various geographies, such as North America, Europe, and Asia-Pacific Latin America, Middle East and North Africa. According to our projections, North America is likely to dominate the market with the majority share of 38% by 2035. Additionally, MENA is anticipated to lift the market with a 20.76% CAGR by 2035 due to the rising adoption of DNA and gene sequencing and the growing prevalence of chronic diseases.

DNA and Gene Cloning Services Market Key Market Insights

The “DNA and Gene Cloning Services Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the companies involved in the DNA and gene cloning services market. The market report highlights the efforts of several manufacturers of small molecules and biologics in this rapidly emerging segment of the pharmaceutical industry. Key takeaways of the market size, competitive landscape, and geographical regions in the DNA and gene cloning services market report are briefly discussed below.

Competitive Landscape of DNA and Gene Cloning Service Providers

Presently, nearly 80 prominent companies are operating in the global market for DNA and gene cloning services. These companies influence the market demand by offering diverse DNA and gene cloning services for different genes. With respect to this, in the competitive landscape of DNA and gene cloning, bacterial expression systems dominate as the preferred choice among industry players. The bacterial expression systems have become the go-to option for researchers and companies which enabling swift and efficient production of desired proteins for a wide array of research, therapeutic, and commercial purposes. 

Additionally, by offering a comprehensive range of services, these key players cater to a broader customer base and capitalize on opportunities in fields such as gene synthesis, gene editing, and functional genomics. Some of the leading companies in the market are Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, and Twist Bioscience. Furthermore, approximately 79% of custom cloning followed by 68% of gene synthesis services are being offered by the maximum number of companies. With regards to a number of patents, more than 1,350 patents have been registered by numerous stakeholders to safeguard their intellectual properties.

Trends Analysis in DNA and Gene Cloning Services Market: Increasing Advancement in Gene Editing Technologies to Expand Market Scope

The DNA and gene cloning services market is evolving exponentially with increasing advancements in gene editing technologies, exemplified by the innovative CRISPR-Cas9 system. The unique precision, efficacy, and adaptability of CRISPR-Cas9 have revolutionized genetic engineering and enabled precise modifications in DNA sequences unprecedented. These breakthrough technologies has not only accelerated research in functional genomics but has also facilitated the development of novel therapeutic interventions. As industries such as medicine and biotechnology increasingly require tailored genetic modifications, the demand for DNA and gene cloning services will likely ascend. 

Moreover, companies offering cloning and sequencing services emerge as indispensable partners, empowering researchers and biopharmaceutical companies to harness the full potential of advanced gene editing tools. Through their strong commitment to innovation, these companies facilitate end-use applications from deciphering gene functions to pioneering life-changing gene therapies. As a result, the relentless evolution of gene editing tools, propelling the DNA and gene cloning services market's growth and providing scientists powerful new ways to understand and manipulate DNA.

Regional Analysis: North America Dominates the Market with its Advanced Biotechnology Infrastructure 

With regard to regional insights, North America has been an eminent region in the market for DNA and gene cloning services due to its robust infrastructure for biotechnology R&D, leading academic research institutions, and a wide range of end-user industries such as pharmaceutical and biotechnology companies in the region. According to market research, around 58% of the service providers are headquartered in North America substantially contributing to the region’s leading position. Apart from this, over 18% of large and very large companies based in the region dominate the market for DNA and gene cloning services with their advanced technologies that foster the development of cutting-edge DNA and gene cloning services. 

In addition, the supportive regulatory environment by agencies such as the FDA encourages research activities for innovation in biotechnology and incentivizes investment in DNA and gene cloning technology services. The leading service providers emphasize collaborative and partnership strategies, and R&D to innovate and improve cloning techniques, optimize processes, and development of new applications. Coupled with the growing demand for personalized medicine further promotes the market demand for the services in the region. For instance, in November 2023, Twist Bioscience, a North American company, unveiled its express genes rapid gene synthesis services. The company leveraged its capability to miniaturize the chemical reaction for DNA creation by employing its silicon-based DNA synthesis platform.

Key Players in DNA and Gene Cloning Services Market 

Examples of key companies engaged in the DNA and gene cloning services market  (which have also been profiled in this market report; the complete list of companies is available in the full report) include Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene and Twist Bioscience. This market report includes an easily searchable Excel database of all the companies who have adopted the DNA and gene cloning services market.

DNA and Gene Cloning Services Market Report Coverage

• A detailed overview of the overall market landscape of DNA cloning and gene cloning service providers, based on several relevant parameters, such as information on their year of establishment, company size (in terms of employee count), region of headquarters (North America, Europe, Asia-Pacific and rest of the world). In addition to this, the chapter also features information on type of service(s) offered (gene synthesis, custom cloning, sub-cloning and others), cloning method(s) used (Restriction Enzyme Based Cloning, PCR Cloning, Ligation Independent Cloning, TA Cloning, Blunt End Cloning, Seamless Cloning and Recombinational Cloning), type of gene(s) cloned (standard gene and complex gene), expression system(s) used (bacterial, mammalian, insect and yeast), cloning vector(s) used (plasmids, bacteriophages, bacterial artificial chromosomes, yeast artificial chromosomes and mammalian artificial chromosomes) and end-user industry (academic and R&D, pharmaceutical and biotechnology companies, and others). 
• An insightful benchmark analysis of the DNA and gene cloning service providers, located in North America, Europe, and Asia-Pacific and Rest of the World. The analysis compares the service providers on the basis of various parameters, such as number of cloning method(s) used, number of expression system(s) used, number of cloning vector(s) used and number of end-user(s). It also highlights the top players in various geographies.
• Elaborate profiles of the key players involved in providing services for DNA and gene cloning. Each profile features a brief overview of the company, its financial information (if available), details on its service portfolio and recent developments with an informed future outlook.
• An in-depth analysis of patents related to DNA and gene cloning, filed / granted since 2017, based on several relevant parameters, such as patent type, publication year, application year, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus area, type of applicant, leading players (on the basis of number of patents), leading assignees (on the basis of number of patents) and patent benchmarking. In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents.
• An analysis of more than 6,900 peer-reviewed, scientific articles related to research on DNA and gene cloning, which have been published since 2017, including analysis based on parameters, such as year of publication, type of cloning, key focus area, popular journals (in terms of number of articles published in DNA and gene cloning services market), leading authors (in terms of number of articles published in DNA and gene cloning services market) and leading first authors (in terms of number of articles published in DNA and gene cloning services market).
• An in-depth analysis of recent events (conferences / seminars / summits / trainings / webinars / workshops) related to DNA and gene cloning that were organized / planned. It features an analysis based on the year of occurrence of the event, event platform, type of event, geographical distribution, emerging agendas / key focus areas, most active event speakers (in terms of number of events), seniority level of event speakers and geographical mapping of the upcoming events.
• A case study on the DNA cloning kits developers, providing information and detailed analysis on kit components, number of reactions, type of cloning method used, type of fragment(s) cloned, cloning time, efficacy and kit shelf life. Further, it also includes a study on the DNA cloning reagents developers, along with a detailed analysis based on reagents’ unit size, concentration, components of reagents, exonuclease activity, product overhangs, heat inactivation temperature and storage temperature. In addition to this, the chapter concludes with the overview of geographical distribution of DNA cloning kits and reagents developers, along with DNA and gene cloning service providers.

Recent Developments in DNA and Gene Cloning Services Market

Several recent developments have taken place in the field of DNA and gene cloning services. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In May 2025, Twist Bioscience and Ginkgo Bioworks revised their collaboration with a new three-year $15 million agreement; Ginkgo prepays annually for DNA products with preferential pricing and no minimums, while Twist acquires licenses to long DNA technology and assets to enhance its synthesis portfolio.
• In February 2025, GenScript launched its Life Science Research Grant Program, providing funding specifically for researchers to purchase GenScript reagents and services, empowering academic and industry projects in gene synthesis and cloning.